166 related articles for article (PubMed ID: 9932222)
1. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
[TBL] [Abstract][Full Text] [Related]
2. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
3. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
4. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
Monami M; Lamanna C; Marchionni N; Mannucci E
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
[TBL] [Abstract][Full Text] [Related]
7. A case of lipoatrophy with human insulin-therapy.
Chantelau E; Reuter M; Schotes S; Starke AA
Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
9. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
10. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
[TBL] [Abstract][Full Text] [Related]
12. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
13. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
15. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
16. [Lipoatrophic diabetes with acanthosis nigricans. Prolonged blood glucose normalization by continuous infusion of insulin].
Leblanc H; Jadaud JM; Dejax C; Saltiel H; Passa P
Presse Med; 1984 Apr; 13(16):987-9. PubMed ID: 6232527
[TBL] [Abstract][Full Text] [Related]
17. [A case of unstable diabetes mellitus after total pancreatectomy controlled by CSII].
Ono K; Matsumoto M; Takii M; Ishizu H
Fukuoka Igaku Zasshi; 1991 Aug; 82(8):467-9. PubMed ID: 1937347
[TBL] [Abstract][Full Text] [Related]
18. [Successful insulin therapy in lipoatrophic diabetes].
Böhmer K; Hauner H; Phlippen R; Gries FA
Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
[TBL] [Abstract][Full Text] [Related]
19. [Insulin-induced lipoatrophy in children].
Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the effects of chromatographically purified insulin TZF-Polfa and highly purified insulin Nordisk on insulin-induced lipoatrophy].
Leowski J; Tatoń J; Czech A; Laz R
Pol Tyg Lek; 1987 Dec; 42(50):1577-80. PubMed ID: 3330794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
